ZNF521 and hepatocellular carcinoma: ZNF521 expression is also deregulated in solid tumors including medulloblastoma cells with an increased tumorigenic potential as well as in other solid tumor types including hepatocellular carcinoma, gastric cancer cells, invasive bladder transitional cell carcinoma as well as breast and ovarian cancers.